PAM
TMO icon

Paradigm Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Paradigm Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
2,300
-2,600
-53% -$1.25M 0.25% 174
2026
Q1 		$2.41M Hold
4,900
– – 0.56% 38
2025
Q4 		$2.84M Sell
4,900
-400
-8% -$226K 0.66% 24
2025
Q3 		$2.57M Hold
5,300
– – 0.59% 34
2025
Q2 		$2.15M Sell
5,300
-2,800
-35% -$1.17M 0.53% 41
2025
Q1 		$4.03M Hold
8,100
– – 1.07% 6
2024
Q4 		$4.21M Buy
8,100
+5,700
+238% +$3.13M 1.15% 7
2024
Q3 		$1.48M Hold
2,400
– – 0.39% 91
2024
Q2 		$1.33M Buy
2,400
+2,100
+700% +$1.2M 0.37% 99
2024
Q1 		$174K Sell
300
-100
-25% -$56.1K 0.04% 304
2023
Q4 		$212K Hold
400
– – 0.06% 297
2023
Q3 		$202K Hold
400
– – 0.06% 293
2023
Q2 		$209K Buy
+400
New +$216K 0.06% 289
2022
Q2 		– Sell
-1,200
Closed -$709K – 458
2022
Q1 		$709K Hold
1,200
– – 0.19% 193
2021
Q4 		$801K Sell
1,200
-200
-14% -$125K 0.2% 196
2021
Q3 		$800K Sell
1,400
-100
-7% -$54.9K 0.22% 194
2021
Q2 		$757K Sell
1,500
-200
-12% -$94.4K 0.19% 225
2021
Q1 		$776K Sell
1,700
-200
-11% -$95.5K 0.21% 218
2020
Q4 		$885K Sell
1,900
-1,920
-50% -$900K 0.25% 159
2020
Q3 		$1.69M Sell
3,820
-600
-14% -$248K 0.52% 38
2020
Q2 		$1.6M Sell
4,420
-700
-14% -$235K 0.49% 43
2020
Q1 		$1.45M Buy
5,120
+1,420
+38% +$448K 0.56% 36
2019
Q4 		$1.2M Buy
3,700
+200
+6% +$60.6K 0.36% 98
2019
Q3 		$1.02M Sell
3,500
-700
-17% -$200K 0.33% 115
2019
Q2 		$1.23M Buy
+4,200
New +$1.16M 0.36% 101
2016
Q2 		– Sell
-551
Closed -$78K – 824
2016
Q1 		$78K Buy
551
+51
+10% +$6.83K 0.01% 506
2015
Q4 		$70.9K Buy
+500
New +$66.7K 0.01% 552
2013
Q3 		– Sell
-52,800
Closed -$4.47M – 853
2013
Q2 		$4.47M Buy
+52,800
New +$4.4M 0.77% 7

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Paradigm Asset Management's TMO Position: Q2 2026 in Review

Paradigm Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 53% in Q2 2026, selling an estimated $1.25M and leaving 2,300 shares worth $1.15M. The position accounts for 0.25% of the portfolio, ranked #174.

Paradigm Asset Management first reported a position in TMO in Q2 2013 and has held it in 28 quarters since. The position peaked at $4.47M in Q2 2013. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Paradigm Asset Management held 2,300 shares of Thermo Fisher Scientific worth $1.15M as of Q2 2026.
  • Paradigm Asset Management sold 2,600 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.25M.
  • Thermo Fisher Scientific made up 0.25% of Paradigm Asset Management's portfolio in Q2 2026, its #174 holding.
  • Paradigm Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 28 quarters since.
  • Paradigm Asset Management's Thermo Fisher Scientific position peaked at $4.47M in Q2 2013.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Paradigm Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.